Fig. 3: Antibody responses at 2 weeks past final vaccine. | npj Vaccines

Fig. 3: Antibody responses at 2 weeks past final vaccine.

From: Impact of adjuvants on the biophysical and functional characteristics of HIV vaccine-elicited antibodies in humans

Fig. 3

A–F Fc Array characterization of antibodies raised against SF2 and Case A V1V2. The isotype and subclass (A–D) and Fcγ receptor binding (E, F) profiles of HIV-specific antibodies are presented. 2AH indicates binding to FcγRIIAH, and 3AF indicates binding to FcγRIIIAF. Median fluorescence intensity (MFI) values for antibodies from individual vaccine recipients are indicated by dots, and violins plots present group distributions, with median values indicated with a bar.

Back to article page